Free Trial

Leerink Partnrs Lifts Earnings Estimates for Schrodinger

Schrodinger logo with Medical background

Key Points

  • Analysts at Leerink Partners have increased their Q3 2025 EPS estimates for Schrodinger, Inc. to ($0.63), up from the previous forecast of ($0.69).
  • Schrodinger reported earnings per share of ($0.59) for its latest quarter, exceeding analysts' expectations by $0.24.
  • The company's revenue increased by 15.7% year-over-year, reaching $54.76 million, surpassing analyst estimates of $52.03 million.
  • Looking to export and analyze Schrodinger data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Schrodinger, Inc. (NASDAQ:SDGR - Free Report) - Analysts at Leerink Partnrs upped their Q3 2025 EPS estimates for shares of Schrodinger in a research note issued to investors on Wednesday, August 6th. Leerink Partnrs analyst M. Foroohar now anticipates that the company will post earnings per share of ($0.63) for the quarter, up from their prior forecast of ($0.69). The consensus estimate for Schrodinger's current full-year earnings is ($2.37) per share. Leerink Partnrs also issued estimates for Schrodinger's Q4 2025 earnings at ($0.12) EPS, FY2025 earnings at ($2.16) EPS, FY2026 earnings at ($1.78) EPS, FY2027 earnings at ($1.97) EPS, FY2028 earnings at ($0.60) EPS and FY2029 earnings at ($0.99) EPS.

Schrodinger (NASDAQ:SDGR - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported ($0.59) earnings per share for the quarter, beating analysts' consensus estimates of ($0.83) by $0.24. The business had revenue of $54.76 million during the quarter, compared to analyst estimates of $52.03 million. Schrodinger had a negative net margin of 76.22% and a negative return on equity of 45.70%. Schrodinger's revenue was up 15.7% compared to the same quarter last year. During the same period last year, the business earned ($0.66) EPS.

A number of other analysts have also commented on SDGR. KeyCorp reduced their price target on shares of Schrodinger from $32.00 to $30.00 and set an "overweight" rating for the company in a research note on Monday, July 14th. Morgan Stanley started coverage on shares of Schrodinger in a research note on Thursday, July 3rd. They issued an "equal weight" rating and a $28.00 price target for the company.

Read Our Latest Analysis on SDGR

Schrodinger Stock Down 0.8%

Shares of SDGR stock opened at $19.21 on Monday. The company has a 50 day moving average price of $21.55 and a 200-day moving average price of $22.50. Schrodinger has a 52 week low of $16.60 and a 52 week high of $28.47. The firm has a market capitalization of $1.41 billion, a PE ratio of -7.75 and a beta of 1.67.

Institutional Trading of Schrodinger

Large investors have recently added to or reduced their stakes in the business. Two Sigma Advisers LP bought a new stake in Schrodinger during the fourth quarter valued at approximately $473,000. Allspring Global Investments Holdings LLC grew its position in Schrodinger by 30.3% during the first quarter. Allspring Global Investments Holdings LLC now owns 174,371 shares of the company's stock valued at $3,442,000 after buying an additional 40,568 shares during the period. GAMMA Investing LLC grew its position in Schrodinger by 118.5% during the first quarter. GAMMA Investing LLC now owns 6,109 shares of the company's stock valued at $121,000 after buying an additional 3,313 shares during the period. BNP Paribas Financial Markets bought a new stake in Schrodinger during the fourth quarter valued at approximately $330,000. Finally, Two Sigma Investments LP bought a new stake in Schrodinger during the fourth quarter valued at approximately $1,939,000. 79.05% of the stock is currently owned by institutional investors.

About Schrodinger

(Get Free Report)

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.

Recommended Stories

Earnings History and Estimates for Schrodinger (NASDAQ:SDGR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Schrodinger Right Now?

Before you consider Schrodinger, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrodinger wasn't on the list.

While Schrodinger currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines